
Journal of International Reproductive Health/Family Planning ›› 2022, Vol. 41 ›› Issue (5): 370-374.doi: 10.12280/gjszjk.20220059
• Original Article • Previous Articles Next Articles
LIANG Hui-zhi, WANG Zhi-hong(
), YANG Pan
Received:2022-02-05
Published:2022-09-15
Online:2022-10-12
Contact:
WANG Zhi-hong
E-mail:Wzh888vv@163.com
LIANG Hui-zhi, WANG Zhi-hong, YANG Pan. Effect of Cryopreservation Time on the Outcome of Frozen-Thawed Embryos Transplant[J]. Journal of International Reproductive Health/Family Planning, 2022, 41(5): 370-374.
Add to citation manager EndNote|Ris|BibTeX
| 组别 | 周期数 | 取卵年龄(岁) | 移植年龄(岁) | 移植日子宫内膜厚度(mm) | 移植胚胎数(枚) | 优质胚胎数(枚) |
|---|---|---|---|---|---|---|
| ≤1年组 | 2 169 | 30.24±4.21 | 30.68±4.28 | 9.97±1.36 | 2.24±0.62 | 1.20±0.76 |
| (1~2]年组 | 1 130 | 30.04±4.02 | 30.94±4.16 | 9.98±1.35 | 2.28±0.66 | 1.16±0.74 |
| (2~3]年组 | 328 | 29.35±3.80ab | 30.78±4.00 | 9.93±1.34 | 2.35±0.64 | 1.28±0.83 |
| (3~4]年组 | 102 | 28.36±3.52ab | 31.58±3.43 | 10.25±1.49 | 2.45±0.64ab | 1.34±0.88 |
| >4年组 | 118 | 28.53±3.35ab | 33.20±3.19abcd | 10.02±1.33 | 2.53±0.64ab | 1.21±0.88 |
| F | 15.192 | 17.766 | 1.215 | 8.872 | 2.254 | |
| P | 0.000 | 0.000 | 0.302 | 0.000 | 0.062 |
| 组别 | 周期数 | 取卵年龄(岁) | 移植年龄(岁) | 移植日子宫内膜厚度(mm) | 移植胚胎数(枚) | 优质胚胎数(枚) |
|---|---|---|---|---|---|---|
| ≤1年组 | 2 169 | 30.24±4.21 | 30.68±4.28 | 9.97±1.36 | 2.24±0.62 | 1.20±0.76 |
| (1~2]年组 | 1 130 | 30.04±4.02 | 30.94±4.16 | 9.98±1.35 | 2.28±0.66 | 1.16±0.74 |
| (2~3]年组 | 328 | 29.35±3.80ab | 30.78±4.00 | 9.93±1.34 | 2.35±0.64 | 1.28±0.83 |
| (3~4]年组 | 102 | 28.36±3.52ab | 31.58±3.43 | 10.25±1.49 | 2.45±0.64ab | 1.34±0.88 |
| >4年组 | 118 | 28.53±3.35ab | 33.20±3.19abcd | 10.02±1.33 | 2.53±0.64ab | 1.21±0.88 |
| F | 15.192 | 17.766 | 1.215 | 8.872 | 2.254 | |
| P | 0.000 | 0.000 | 0.302 | 0.000 | 0.062 |
| 组别 | 周期数 | 胚胎存活率 | 胚胎完好率 | 优质胚胎率 | 着床率 |
|---|---|---|---|---|---|
| ≤1年组 | 2 169 | 99.0(4 870/4 920) | 96.0(4 675/4 870) | 53.3(2 596/4 870) | 27.8(1 353/4 870) |
| (1~2]年组 | 1 130 | 99.3(2 579/2 597) | 96.9(2 500/2 579) | 51.0(1 315/2 579) | 29.3(756/2 579) |
| (2~3]年组 | 328 | 99.0(770/778) | 96.1(740/770) | 54.5(420/770) | 31.0(239/770) |
| (3~4]年组 | 102 | 100.0(250/250) | 98.0(245/250) | 54.8(137/250) | 28.8(72/250) |
| >4年组 | 118 | 99.7(298/299) | 96.3(287/298) | 48.0(143/298) | 24.5(73/298) |
| χ2 | 5.573 | 9.164 | 7.857 | 6.851 | |
| P | 0.233 | 0.057 | 0.097 | 0.144 |
| 组别 | 周期数 | 胚胎存活率 | 胚胎完好率 | 优质胚胎率 | 着床率 |
|---|---|---|---|---|---|
| ≤1年组 | 2 169 | 99.0(4 870/4 920) | 96.0(4 675/4 870) | 53.3(2 596/4 870) | 27.8(1 353/4 870) |
| (1~2]年组 | 1 130 | 99.3(2 579/2 597) | 96.9(2 500/2 579) | 51.0(1 315/2 579) | 29.3(756/2 579) |
| (2~3]年组 | 328 | 99.0(770/778) | 96.1(740/770) | 54.5(420/770) | 31.0(239/770) |
| (3~4]年组 | 102 | 100.0(250/250) | 98.0(245/250) | 54.8(137/250) | 28.8(72/250) |
| >4年组 | 118 | 99.7(298/299) | 96.3(287/298) | 48.0(143/298) | 24.5(73/298) |
| χ2 | 5.573 | 9.164 | 7.857 | 6.851 | |
| P | 0.233 | 0.057 | 0.097 | 0.144 |
| 组别 | 周期数 | 临床妊娠率 | 异位妊娠率 | 流产率 | 活产率 | 多胎妊娠率 |
|---|---|---|---|---|---|---|
| ≤1年组 | 2 169 | 47.9(1 040/2 169) | 2.8(29/1 040) | 20.1(209/1 040) | 37.0(802/2 169) | 27.4(285/1 040) |
| (1~2]年组 | 1 130 | 50.0(5 65/1 130) | 1.8(10/565) | 20.0(113/565) | 39.1(442/1 130) | 29.2(165/565) |
| (2~3]年组 | 328 | 61.9(203/328)ab | 1.5(3/203) | 12.3(25/203) | 53.4(175/328)ab | 31.0(63/203) |
| (3~4]年组 | 102 | 53.9(55/102) | 5.5(3/55) | 18.2(10/55) | 41.2(42/102) | 25.5(14/55) |
| >4年组 | 118 | 47.5(56/118) | 1.8(1/56) | 26.8(15/56) | 33.9(40/118) | 30.4(17/56) |
| χ2 | 23.112 | 4.651 | 8.980 | 33.637 | 1.719 | |
| P | 0.000 | 0.325 | 0.062 | 0.000 | 0.787 |
| 组别 | 周期数 | 临床妊娠率 | 异位妊娠率 | 流产率 | 活产率 | 多胎妊娠率 |
|---|---|---|---|---|---|---|
| ≤1年组 | 2 169 | 47.9(1 040/2 169) | 2.8(29/1 040) | 20.1(209/1 040) | 37.0(802/2 169) | 27.4(285/1 040) |
| (1~2]年组 | 1 130 | 50.0(5 65/1 130) | 1.8(10/565) | 20.0(113/565) | 39.1(442/1 130) | 29.2(165/565) |
| (2~3]年组 | 328 | 61.9(203/328)ab | 1.5(3/203) | 12.3(25/203) | 53.4(175/328)ab | 31.0(63/203) |
| (3~4]年组 | 102 | 53.9(55/102) | 5.5(3/55) | 18.2(10/55) | 41.2(42/102) | 25.5(14/55) |
| >4年组 | 118 | 47.5(56/118) | 1.8(1/56) | 26.8(15/56) | 33.9(40/118) | 30.4(17/56) |
| χ2 | 23.112 | 4.651 | 8.980 | 33.637 | 1.719 | |
| P | 0.000 | 0.325 | 0.062 | 0.000 | 0.787 |
| 组别 | 周期数 | 新生儿数 | 分娩孕周 (周,$\bar{x} \pm x$) | 出生体质量 (g,$\bar{x} \pm x$) | 男孩占比 [%(n/n)] |
|---|---|---|---|---|---|
| ≤1年组 | 2 169 | 963 | 37.97±2.37 | 3 101.20±655.85 | 53.1(511/963) |
| (1~2]年组 | 1 130 | 556 | 37.95±2.29 | 3 094.88±637.90 | 52.3(291/556) |
| (2~3]年组 | 328 | 217 | 38.25±2.08 | 3 120.09±575.93 | 49.8(108/217) |
| (3~4]年组 | 102 | 50 | 38.19±1.53 | 3 298.45±563.64 | 50.0(25/50) |
| >4年组 | 118 | 47 | 38.03±1.12 | 3 271.75±365.90 | 51.1(24/47) |
| F或 χ2 | 0.850 | 2.226 | 0.917 | ||
| P | 0.495 | 0.065 | 0.922 |
| 组别 | 周期数 | 新生儿数 | 分娩孕周 (周,$\bar{x} \pm x$) | 出生体质量 (g,$\bar{x} \pm x$) | 男孩占比 [%(n/n)] |
|---|---|---|---|---|---|
| ≤1年组 | 2 169 | 963 | 37.97±2.37 | 3 101.20±655.85 | 53.1(511/963) |
| (1~2]年组 | 1 130 | 556 | 37.95±2.29 | 3 094.88±637.90 | 52.3(291/556) |
| (2~3]年组 | 328 | 217 | 38.25±2.08 | 3 120.09±575.93 | 49.8(108/217) |
| (3~4]年组 | 102 | 50 | 38.19±1.53 | 3 298.45±563.64 | 50.0(25/50) |
| >4年组 | 118 | 47 | 38.03±1.12 | 3 271.75±365.90 | 51.1(24/47) |
| F或 χ2 | 0.850 | 2.226 | 0.917 | ||
| P | 0.495 | 0.065 | 0.922 |
| 因素 | B | SE | Wald χ2 | OR | 95%CI | P | |
|---|---|---|---|---|---|---|---|
| 下限 | 上限 | ||||||
| 取卵年龄(岁) | -0.016 | 0.014 | 1.408 | 0.984 | 0.958 | 1.011 | 0.235 |
| 移植年龄(岁) | -0.013 | 0.013 | 0.925 | 0.987 | 0.962 | 1.013 | 0.336 |
| 冻存时间(年) | 0.059 | 0.033 | 3.124 | 1.061 | 0.994 | 1.133 | 0.077 |
| 优质胚胎数(枚) | 0.401 | 0.043 | 85.374 | 1.493 | 1.371 | 1.625 | 0.000 |
| 移植胚胎数(枚) | 0.201 | 0.053 | 14.220 | 1.223 | 1.101 | 1.357 | 0.000 |
| 因素 | B | SE | Wald χ2 | OR | 95%CI | P | |
|---|---|---|---|---|---|---|---|
| 下限 | 上限 | ||||||
| 取卵年龄(岁) | -0.016 | 0.014 | 1.408 | 0.984 | 0.958 | 1.011 | 0.235 |
| 移植年龄(岁) | -0.013 | 0.013 | 0.925 | 0.987 | 0.962 | 1.013 | 0.336 |
| 冻存时间(年) | 0.059 | 0.033 | 3.124 | 1.061 | 0.994 | 1.133 | 0.077 |
| 优质胚胎数(枚) | 0.401 | 0.043 | 85.374 | 1.493 | 1.371 | 1.625 | 0.000 |
| 移植胚胎数(枚) | 0.201 | 0.053 | 14.220 | 1.223 | 1.101 | 1.357 | 0.000 |
| 因素 | B | SE | Wald χ2 | OR | 95%CI | P | |
|---|---|---|---|---|---|---|---|
| 下限 | 上限 | ||||||
| 取卵年龄(岁) | -0.004 | 0.014 | 0.072 | 0.996 | 0.969 | 1.024 | 0.789 |
| 移植年龄(岁) | -0.020 | 0.014 | 2.126 | 0.980 | 0.954 | 1.007 | 0.145 |
| 冻存时间(年) | 0.063 | 0.033 | 3.541 | 1.065 | 0.997 | 1.137 | 0.060 |
| 优质胚胎数(枚) | 0.315 | 0.044 | 51.071 | 1.371 | 1.257 | 1.495 | 0.000 |
| 移植胚胎数(枚) | 0.165 | 0.055 | 9.026 | 1.179 | 1.059 | 1.312 | 0.003 |
| 因素 | B | SE | Wald χ2 | OR | 95%CI | P | |
|---|---|---|---|---|---|---|---|
| 下限 | 上限 | ||||||
| 取卵年龄(岁) | -0.004 | 0.014 | 0.072 | 0.996 | 0.969 | 1.024 | 0.789 |
| 移植年龄(岁) | -0.020 | 0.014 | 2.126 | 0.980 | 0.954 | 1.007 | 0.145 |
| 冻存时间(年) | 0.063 | 0.033 | 3.541 | 1.065 | 0.997 | 1.137 | 0.060 |
| 优质胚胎数(枚) | 0.315 | 0.044 | 51.071 | 1.371 | 1.257 | 1.495 | 0.000 |
| 移植胚胎数(枚) | 0.165 | 0.055 | 9.026 | 1.179 | 1.059 | 1.312 | 0.003 |
| [1] |
秦宁馨, 赵文龙, 周志阳, 等. 冻融胚胎移植对子代的近、远期影响[J]. 上海交通大学学报(医学版), 2021, 41(5):653-658. doi: 10.3969/j.issn.1674-8115.2021.05.016.
doi: 10.3969/j.issn.1674-8115.2021.05.016 |
| [2] |
Nagy ZP, Shapiro D, Chang CC. Vitrification of the human embryo: a more efficient and safer in vitro fertilization treatment[J]. Fertil Steril, 2020, 113(2):241-247. doi: 10.1016/j.fertnstert.2019.12.009.
doi: 10.1016/j.fertnstert.2019.12.009 URL |
| [3] |
马韵, 郑梅玲. 不明原因复发性流产发病机制研究进展[J]. 中华妇幼临床医学杂志(电子版), 2016, 12(2):237-240. doi: 10.3877/cma.j.issn.1673-5250.2016.02.020.
doi: 10.3877/cma.j.issn.1673-5250.2016.02.020 |
| [4] |
Steer CV, Mills CL, Tan SL, et al. The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer programme[J]. Hum Reprod, 1992, 7(1):117-119. doi: 10.1093/oxfordjournals.humrep.a137542.
doi: 10.1093/oxfordjournals.humrep.a137542 pmid: 1551945 |
| [5] |
Coughlan C, Ledger W, Wang Q, et al. Recurrent implantation failure: definition and management[J]. Reprod Biomed Online, 2014, 28(1):14-38. doi: 10.1016/j.rbmo.2013.08.011.
doi: 10.1016/j.rbmo.2013.08.011 pmid: 24269084 |
| [6] |
中华人民共和国卫生部. 人类辅助生殖技术规范[J]. 中国生育健康杂志, 2004, 15(1):4-9. doi: 10.3969/j.issn.1671-878X.2004.01.001.
doi: 10.3969/j.issn.1671-878X.2004.01.001 |
| [7] |
Bojic S, Murray A, Bentley BL, et al. Winter is coming: the future of cryopreservation[J]. BMC Biol, 2021, 19(1):56. doi: 10.1186/s12915-021-00976-8.
doi: 10.1186/s12915-021-00976-8 pmid: 33761937 |
| [8] |
Zhang X, Wu S, Hao G, et al. Prolonged Cryopreservation Negatively Affects Embryo Transfer Outcomes Following the Elective Freeze-All Strategy: A Multicenter Retrospective Study[J]. Front Endocrinol(Lausanne), 2021, 12:709648. doi: 10.3389/fendo.2021.709648.
doi: 10.3389/fendo.2021.709648 |
| [9] |
Mazur P. Freezing of living cells: mechanisms and implications[J]. Am J Physiol, 1984, 247(3 Pt 1):C125-C142. doi: 10.1152/ajpcell.1984.247.3.C125.
doi: 10.1152/ajpcell.1984.247.3.C125 |
| [10] |
Kopeika J, Thornhill A, Khalaf Y. The effect of cryopreservation on the genome of gametes and embryos: principles of cryobiology and critical appraisal of the evidence[J]. Hum Reprod Update, 2015, 21(2):209-227. doi: 10.1093/humupd/dmu063.
doi: 10.1093/humupd/dmu063 pmid: 25519143 |
| [11] |
Verheijen M, Lienhard M, Schrooders Y, et al. DMSO induces drastic changes in human cellular processes and epigenetic landscape in vitro[J]. Sci Rep, 2019, 9(1):4641. doi: 10.1038/s41598-019-40660-0.
doi: 10.1038/s41598-019-40660-0 pmid: 30874586 |
| [12] |
Dowling-Lacey D, Mayer JF, Jones E, et al. Live birth from a frozen-thawed pronuclear stage embryo almost 20 years after its cryopreservation[J]. Fertil Steril, 2011, 95(3):1120.e1-e3. doi: 10.1016/j.fertnstert.2010.08.056.
doi: 10.1016/j.fertnstert.2010.08.056 |
| [13] |
Testart J, Lassalle B, Forman R, et al. Factors influencing the success rate of human embryo freezing in an in vitro fertilization and embryo transfer program[J]. Fertil Steril, 1987, 48(1):107-112. doi: 10.1016/s0015-0282(16)59298-x.
doi: 10.1016/s0015-0282(16)59298-x pmid: 3595906 |
| [14] |
Lavara R, Baselga M, Vicente JS. Does storage time in LN2 influence survival and pregnancy outcome of vitrified rabbit embryos?[J]. Theriogenology, 2011, 76(4):652-657. doi: 10.1016/j.theriogenology.2011.03.018.
doi: 10.1016/j.theriogenology.2011.03.018 pmid: 21664667 |
| [15] |
Li J, Yin M, Wang B, et al. The effect of storage time after vitrification on pregnancy and neonatal outcomes among 24 698 patients following the first embryo transfer cycles[J]. Hum Reprod, 2020, 35(7):1675-1684. doi: 10.1093/humrep/deaa136.
doi: 10.1093/humrep/deaa136 URL |
| [16] |
全松, 黄国宁, 孙海翔, 等. 冷冻胚胎保存时限的中国专家共识[J]. 生殖医学杂志, 2018, 27(10):925-931. doi: 10.3969/j.issn.1004-3845.2018.10.001.
doi: 10.3969/j.issn.1004-3845.2018.10.001 |
| [17] |
Li W, Zhao W, Xue X, et al. Influence of storage time on vitrified human cleavage-stage embryos froze in open system[J]. Gynecol Endocrinol, 2017, 33(2):96-99. doi: 10.1080/09513590.2016.1207166.
doi: 10.1080/09513590.2016.1207166 pmid: 27449701 |
| [18] |
Zhu Q, Lin J, Gao H, et al. The Association Between Embryo Quality, Number of Transferred Embryos and Live Birth Rate After Vitrified Cleavage-Stage Embryos and Blastocyst Transfer[J]. Front Physiol, 2020, 11:930. doi: 10.3389/fphys.2020.00930.
doi: 10.3389/fphys.2020.00930 pmid: 32922305 |
| [19] |
刘艳丽, 申峻涵, 张玉超, 等. 胚胎冻存时间对冻胚周期临床结局和新生儿结局的影响[J]. 郑州大学学报(医学版), 2021, 56(6):828-834. doi: 10.13705/j.issn.1671-6825.2021.01.006.
doi: 10.13705/j.issn.1671-6825.2021.01.006 |
| [20] |
马海兰, 罗克莉, 龚斐, 等. 辅助生殖技术助孕出生婴儿性别比例的初步调查[J]. 生殖医学杂志, 2013, 22(3):203-204. doi: 10.3969/j.issn.1004-3845.2013.03.014.
doi: 10.3969/j.issn.1004-3845.2013.03.014 |
| [1] | CHEN Yan, WANG Shan-lin, MA Zhen-hua, GAO Hui, ZHOU Rong, DING Ming-ming, XIANG Min. Analysis of Influencing Factors of Adverse Psychological State of Primipara in Late Pregnancy and Its Impact on Maternal and Infant Outcome [J]. Journal of International Reproductive Health/Family Planning, 2026, 45(4): 270-275. |
| [2] | DU Chao, CHENG Xu, YU Xin-tong, SUN Kai-xuan, ZHANG Qian, ZHOU Jing. Research on Dyadic Coping and Anxiety/Depression in Separated Couples with Infertility Undergoing IVF-ET Based on Actor-Partner Interdependence Model [J]. Journal of International Reproductive Health/Family Planning, 2026, 45(3): 190-195. |
| [3] | ZHU Yan-jun, WEN Yi, GONG Fei. Transabdominal Ultrasound-Guided Oocyte Retrieval in Ovulation Induction Cycle: A Report of Two Cases [J]. Journal of International Reproductive Health/Family Planning, 2026, 45(3): 218-223. |
| [4] | WANG Wei, DAI Bai, SHA Ri-na, TUO Ya. Research Progress on the Mechanism of KIF18B in Female Reproductive Function [J]. Journal of International Reproductive Health/Family Planning, 2026, 45(3): 230-235. |
| [5] | KUANG Qian-qian, ZHAO Xian, ZHANG Ning, XI Jin, YUAN Rong-li, LIU Qi, WANG Meng-jing. Research Progress on the Effect and Mechanism of Acupuncture Intervention at Different Stages of IVF-ET [J]. Journal of International Reproductive Health/Family Planning, 2026, 45(3): 247-252. |
| [6] | ZHOU Jun, TIAN Yan-ya, PANG Hai-yan, HAN Xue, WANG Gui-ling. Application of Resveratrol in Sperm Cryopreservation and Research Progress [J]. Journal of International Reproductive Health/Family Planning, 2026, 45(2): 133-138. |
| [7] | KONG Jing, YU Lan, ZHANG Cui-lian. The Impact of Vitamin D on Assisted Reproductive Technology Outcomes in Women with Polycystic Ovary Syndrome [J]. Journal of International Reproductive Health/Family Planning, 2026, 45(2): 154-159. |
| [8] | XU Dan, ZHOU Qiao, JI Hui. Effects of Endometrial Preparation Protocols on the Live Birth Outcome after Endometrial Polypectomy [J]. Journal of International Reproductive Health/Family Planning, 2026, 45(1): 1-5. |
| [9] | CAI Li-yi, JIANG Yu-ying, ZHUANG Qian-mei, CHEN Xin-ying. The Genetic Etiology Analysis of A t(8;13) Balanced Chromosomal Translocation Family [J]. Journal of International Reproductive Health/Family Planning, 2026, 45(1): 18-22. |
| [10] | CHEN Jia-lang, ZHANG Yun-shan, WANG Guang-teng, PANG Ze-hui. The Impact of Sperm DNA Fragmentation on Intrauterine Insemination Outcomes and Intervention Strategies [J]. Journal of International Reproductive Health/Family Planning, 2026, 45(1): 40-44. |
| [11] | HUANG Ru, JIN Meng-han, ZHONG Yu-nong, WANG Ke-han, MENG Qing-xia. Research Progress on DNA Methylation of Gametes, Embryos and Offspring from Assisted Reproductive Technology [J]. Journal of International Reproductive Health/Family Planning, 2026, 45(1): 45-48. |
| [12] | LI Huan, CHEN Yi, JIANG Xiang-long, CHEN Sheng-hui, XIONG Qing. Application of Soybean Lecithin in the Cryopreservation of Human Sperm [J]. Journal of International Reproductive Health/Family Planning, 2026, 45(1): 6-10. |
| [13] | TONG Chen-ye, QIAN Wen, HUANG Li-min, JI Hong, NI Ying. The Current Situation of Appropriate Medication in IVF Patients and Its Impact on Pregnancy Outcomes [J]. Journal of International Reproductive Health/Family Planning, 2025, 44(6): 441-447. |
| [14] | YANG Jing, JI Dong-mei. Progress in Enucleated Oocyte Donation and Its Clinical Application [J]. Journal of International Reproductive Health/Family Planning, 2025, 44(6): 496-500. |
| [15] | ZHANG Dong-can, HE Ling, ZHANG Hui-ying, TIAN Wen-yan. Research Progress on Diagnosis and Treatment of Arcuate Uterus [J]. Journal of International Reproductive Health/Family Planning, 2025, 44(6): 506-510. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||